We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Gene Expression Monitoring of Mononuclear Cells (MNC) Subpopulations and Immunological Status and Metabolome Defining of Healthy Population

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01052649
Recruitment Status : Completed
First Posted : January 20, 2010
Last Update Posted : January 20, 2010
Sponsor:
Information provided by:
Blood Transfusion Centre of Slovenia

Brief Summary:
Study on healthy volunteers is focusing on analysis of transcriptome profile fluctuations in healthy population in three mononuclear cell types (CD4+ cells, CD56+ cells and CD4+CD25+ cells)and should provide a reference for comparison with transcriptomic data of any disease state.Furthermore, metabolome and immunological status are defined on same samples.

Condition or disease Intervention/treatment
Gene Expression Metabolomics Immunological Status Other: Blood sampling

Study Type : Observational
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Gene Expression Monitoring of Peripheral Blood Mononuclear Cells Subpopulations (CD4+ Cells, CD56+ Cells and CD4+CD25+ Cells) and Immunological Status and Metabolome Defining of Healthy Population
Study Start Date : August 2008

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort Intervention/treatment
Healthy volunteers Other: Blood sampling




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
healthy population
Criteria

Inclusion Criteria:

  • age: 20-70 years
  • healthy

Exclusion Criteria:

  • acute or chronic diseases
  • pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01052649


Locations
Slovenia
Blood Transfusion Centre of Slovenia
Ljubljana, Slovenia, 1000
Sponsors and Collaborators
Blood Transfusion Centre of Slovenia

ClinicalTrials.gov Identifier: NCT01052649     History of Changes
Other Study ID Numbers: MNC -1-4
First Posted: January 20, 2010    Key Record Dates
Last Update Posted: January 20, 2010
Last Verified: July 2009

Keywords provided by Blood Transfusion Centre of Slovenia:
MNC subpopulations
Gene Expression
Metabolomics
Immunological Status